Specialty drugs prescribed for hepatitis C and cancer treatments are taking prescription drug costs to new levels for many Americans. The numbers speak for themselves:
- Estimated number of individuals in the U.S. who are taking medicines worth more than $50,000 annually rose 63%.
- Estimated number of individuals in the U.S. who are taking medicines worth more than $100,000 annually skyrocketed 193%.
Read the full article from the Wall Street Journal here.
You must be logged in to post a comment.